Anuh Pharma Ltd

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish trend. Despite a modest day gain of 1.07%, the stock’s technical indicators present a complex picture, with some weekly signals turning mildly bullish while monthly trends remain cautious. This analysis delves into the recent technical parameter changes, evaluating key momentum indicators such as MACD, RSI, moving averages, and others to provide a comprehensive view of the stock’s near-term outlook.

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, a rating that was last updated on 04 February 2026. While this rating change occurred in early February, the analysis and financial metrics presented here reflect the stock's current position as of 01 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

For the third consecutive session, Anuh Pharma Ltd has declined, culminating in a fresh 52-week low of Rs 66.83 on 30 Mar 2026. This latest drop extends the stock’s downward trend, with a cumulative loss of 5.3% over the past three days, underperforming its sector by nearly 3% today alone.

Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. Despite some mildly bullish signals on weekly MACD and KST indicators, the overall technical landscape remains subdued, reflecting the stock’s recent price decline and challenging market conditions.

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend. Despite a recent downgrade in its Mojo Grade to Sell from Strong Sell, the stock’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others reinforce bearish pressures.

Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. Recent technical indicators, including MACD, RSI, and moving averages, signal increasing downside pressure, reflecting the stock’s underperformance relative to benchmarks such as the Sensex.

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Anuh Pharma Ltd has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend, reflecting a nuanced change in investor sentiment. Despite a recent day gain of 2.54%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, underscoring the need for cautious analysis in the Pharmaceuticals & Biotechnology sector.

Anuh Pharma Ltd (Stock ID: 905552) has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite some mildly bullish weekly indicators, the overall technical landscape remains cautious, with key metrics such as moving averages and monthly MACD signalling downward pressure. This article analyses the recent technical parameter changes, price momentum, and how these signals align with the broader market context.

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 February 2026, providing investors with the most recent insights into the company’s performance and outlook.

Anuh Pharma Ltd, a player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish trend. Despite a recent day gain of 3.73%, the company’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others remain subdued. This article analyses the latest technical parameters, price momentum, and relative performance against the broader market to provide a comprehensive view for investors.

Anuh Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven primarily by a decline in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This revaluation comes amid a mixed performance backdrop in the Pharmaceuticals & Biotechnology sector, where peer comparisons and historical benchmarks provide a nuanced perspective on the stock’s price attractiveness and investment potential.

Anuh Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite some mildly bullish weekly signals, the overall technical landscape suggests caution for investors as the stock navigates downward pressures amid mixed momentum readings.

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Anuh Pharma Ltd has exhibited a notable shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend, supported by mixed signals from key technical indicators. Despite a recent 4.34% gain in the stock price, the company’s overall Mojo Grade remains a Sell, reflecting cautious sentiment amid volatile market conditions and sectoral challenges.